A new wave of OIG scrutiny is putting ophthalmology and optometry services under the microscope, making it more important than ever to validate modifier use, medical necessity, and documentation support before patterns become repayment exposure.
Eye services remain a steady target for audit activity, and recent OIG reviews point to a clear pattern: outlier billing data leads to deeper scrutiny of documentation, modifier use, and medical necessity.
In ophthalmology and optometry, that risk often shows up in a few key areas. E/M services billed on the same day as intravitreal injections. High-level nursing facility E/M services billed by optometrists. Diagnostic tests billed together, or repeated more often than payer policy supports, without clear clinical justification in the record.
This eBrief explores the most important takeaways from recent OIG activity and what they mean for organizations trying to reduce repayment exposure and strengthen defensibility.
You’ll hear practical guidance on how to evaluate:
- Modifier 25 use with same-day intravitreal injections and E/M services
- Whether documentation clearly supports a significant, separately identifiable service
- High-level optometry E/M patterns in skilled nursing facilities
- Mutually exclusive testing combinations and the use of XU/59 modifiers
- Frequency limits, LCD expectations, and medical necessity documentation
- Quick self-audit priorities to help identify risk early